Walter Pierre Bouman
Transgender and anxiety: a comparative study between transgender people and the general population
Bouman, Walter Pierre; Claes, Laurence; Brewin, Nicky; Crawford, John R.; Millet, Nessa; Fernandez-Aranda, Fernando; Arcelus, Jon
John R. Crawford
JON ARCELUS ALONSO Jon.Arcelus@nottingham.ac.uk
Clinical Professor in Mental Health & Transgender Health
Background: Anxiety disorders pose serious public health problems. The data available on anxiety disorders in the transgender population is limited by the small numbers, the lack of a matched controlled population and the selection of a nonhomogenous group of transgender people.
Aims: The aims of the study were (1) to determine anxiety symptomatology (based on the HADS) in a nontreated transgender population and to compare it to a general population sample matched by age and gender; (2) to investigate the predictive role of specific variables, including experienced gender, self-esteem, victimization, social support, interpersonal functioning, and cross-sex hormone use regarding levels of anxiety symptomatology; and (3) to investigate differences in anxiety symptomatology between transgender people on cross-sex hormone treatment and not on hormone treatment.
Methods: A total of 913 individuals who self-identified as transgender attending a transgender health service during a 3-year period agreed to participate. For the first aim of the study, 592 transgender people not on treatment were matched by age and gender, with 3,816 people from the general population. For the second and third aim, the whole transgender population was included.
Measurements: Sociodemographic variables and measures of depression and anxiety (HADS), self-esteem (RSE), victimization (ETS), social support (MSPSS), and interpersonal functioning (IIP-32).
Results: Compared with the general population transgender people had a nearly threefold increased risk of probable anxiety disorder (all p < .05). Low self-esteem and interpersonal functioning were found to be significant predictors of anxiety symptoms. Trans women on treatment with cross-sex hormones were found to have lower levels of anxiety disorder symptomatology.
Conclusions: Transgender people (particularly trans males) have higher levels of anxiety symptoms suggestive of possible anxiety disorders compared to the general population. The findings that self-esteem, interpersonal functioning, and hormone treatment are associated with lower levels of anxiety symptoms indicate the need for clinical interventions targeting self-esteem and interpersonal difficulties and highlight the importance of quick access to transgender health services.
Bouman, W. P., Claes, L., Brewin, N., Crawford, J. R., Millet, N., Fernandez-Aranda, F., & Arcelus, J. (in press). Transgender and anxiety: a comparative study between transgender people and the general population. International Journal of Transgenderism, https://doi.org/10.1080/15532739.2016.1258352
|Journal Article Type||Article|
|Acceptance Date||Dec 1, 2016|
|Online Publication Date||Dec 15, 2016|
|Deposit Date||Jan 6, 2017|
|Publicly Available Date||Jan 6, 2017|
|Journal||International Journal of Transgenderism|
|Publisher||Taylor & Francis (Routledge)|
|Peer Reviewed||Peer Reviewed|
|Keywords||Anxiety, cross-sex hormone treatment, gender dysphoria, HADS, interpersonal functioning, mental health, self-esteem, transgender|
|Copyright Statement||Copyright information regarding this work can be found at the following address: http://eprints.nottingh.../end_user_agreement.pdf|
|Additional Information||“This is an Accepted Manuscript of an article published by Taylor & Francis in International Journal of Transgenderism on 15/12/2016, available online: http://www.tandfonline....0/15532739.2016.1258352|
Transgender and Anxiety second submission.pdf
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf
You might also like
Mental health and quality of life in non-binary transgender adults: a case control study
Endocrinology of transgender medicine